52 results
8-K
EX-99.1
ORGS
Orgenesis Inc
7 Mar 24
Orgenesis Inc. Announces $2.3 Million Private Placement
12:11pm
others participation from healthcare industry executives and physicians.
The securities to be sold in this private placement will not be registered under
8-K
ORGS
Orgenesis Inc
29 Dec 23
Departure of Directors or Certain Officers
4:05pm
company, from 2014 to May 2023. Mr. Miller has over 30 years of healthcare and finance industry experience, including 14 years leading finance functions … -stage specialty pharmaceutical company.
From 2000 to 2009, Mr. Miller developed broad healthcare functional experience with roles in Corporate
8-K
4suxvegq
7 Nov 22
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-99.1
b01o4ih krx
16 Nov 20
Other Events
2:36pm
8-K
EX-99.1
ur6l 5fq5odpzy
1 Oct 20
Orgenesis Announces Agreement to Acquire Koligo Therapeutics, a Leader in Personalized Cell Therapies
5:04pm
424B3
11z76n6op nsg
28 Apr 20
Prospectus supplement
2:15pm
8-K
EX-2.1
1jxczrs1x swlgr
3 Feb 20
Entry into a Material Definitive Agreement
3:16pm
8-K
g0f zj7oaw57twzismq
22 Jan 20
Orgenesis Inc. Announces $9.2 Million Private Placement
12:00am